-
1
-
-
84866268783
-
Management of hyperglycemia in type 2 diabetes: A patient-centered approach
-
1:CAS:528:DC%2BC38Xps1Kitb4%3D 3357214 22517736 10.2337/dc12-0413
-
Inzucchi SE, Nauck M, Bergenstal RM, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Diabetes Care. 2012;35:1364-79.
-
(2012)
Diabetes Care
, vol.35
, pp. 1364-1379
-
-
Inzucchi, S.E.1
Nauck, M.2
Bergenstal, R.M.3
-
2
-
-
33644798145
-
Resistance to insulin therapy among patients and providers: Results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study
-
16249538 10.2337/diacare.28.11.2673
-
Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study. Diabetes Care. 2005;28:2673-9.
-
(2005)
Diabetes Care
, vol.28
, pp. 2673-2679
-
-
Peyrot, M.1
Rubin, R.R.2
Lauritzen, T.3
-
3
-
-
77953044294
-
Barriers to insulin initiation: The translating research into action for diabetes insulin starts project
-
2845015 20086256 10.2337/dc09-1184
-
Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33:733-5.
-
(2010)
Diabetes Care
, vol.33
, pp. 733-735
-
-
Karter, A.J.1
Subramanian, U.2
Saha, C.3
-
4
-
-
37749054852
-
Barriers to the initiation of, and persistence with, insulin therapy
-
1:CAS:528:DC%2BD1cXhslOksbs%3D 17977482 10.1185/030079907X242638
-
Oliveria SA, Menditto LA, Ulcickas Yood M, Koo YH, Wells KE, McCarthy BD. Barriers to the initiation of, and persistence with, insulin therapy. Curr Med Res Opin. 2007;23:3105-12.
-
(2007)
Curr Med Res Opin.
, vol.23
, pp. 3105-3112
-
-
Oliveria, S.A.1
Menditto, L.A.2
Ulcickas Yood, M.3
Koo, Y.H.4
Wells, K.E.5
McCarthy, B.D.6
-
5
-
-
84862653963
-
What can we learn from patient-reported outcomes of insulin pen devices?
-
3262728 22226279
-
Anderson BJ, Redondo MJ. What can we learn from patient-reported outcomes of insulin pen devices? J Diabetes Sci Technol. 2011;5:1563-71.
-
(2011)
J Diabetes Sci Technol.
, vol.5
, pp. 1563-1571
-
-
Anderson, B.J.1
Redondo, M.J.2
-
6
-
-
50149104154
-
Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus
-
18627641 10.1185/03007990802278644
-
Peyrot M, Rubin RR. Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus. Curr Med Res Opin. 2008;24:2413-22.
-
(2008)
Curr Med Res Opin.
, vol.24
, pp. 2413-2422
-
-
Peyrot, M.1
Rubin, R.R.2
-
7
-
-
77956139699
-
Health economics and compliance of vials/syringes versus pen devices: A review of the evidence
-
20515297
-
Asche CV, Shane-McWhorter L, Raparla S. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence. Diabetes Technol Ther. 2010;12:S101-8.
-
(2010)
Diabetes Technol Ther
, vol.12
-
-
Asche, C.V.1
Shane-Mcwhorter, L.2
Raparla, S.3
-
8
-
-
33751566656
-
Medication adherence and the associated health economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third party managed care claims data
-
17157128 10.1016/j.clinthera.2006.10.004
-
Lee W, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third party managed care claims data. Clin Ther. 2006;28:1712-23.
-
(2006)
Clin Ther
, vol.28
, pp. 1712-1723
-
-
Lee, W.1
Balu, S.2
Cobden, D.3
Joshi, A.V.4
Pashos, C.L.5
-
9
-
-
38449113522
-
Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: A retrospective database analysis
-
10.1016/j.clinthera.2007.07.007
-
Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther. 2007;29:1294-305.
-
(2007)
Clin Ther.
, vol.29
, pp. 1294-1305
-
-
Pawaskar, M.D.1
Camacho, F.T.2
Anderson, R.T.3
Cobden, D.4
Joshi, A.V.5
Balkrishnan, R.6
-
10
-
-
69949117621
-
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met + SU): A randomised controlled trial
-
1:CAS:528:DC%2BD1MXhtVygtLnE 2744824 19688338 10.1007/s00125-009-1472-y
-
Russell-Jones D, Vaag A, Schmitz O, et al. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met + SU): a randomised controlled trial. Diabetologia. 2009;52:2046-55.
-
(2009)
Diabetologia.
, vol.52
, pp. 2046-2055
-
-
Russell-Jones, D.1
Vaag, A.2
Schmitz, O.3
-
11
-
-
84872290285
-
Validating the adapted diabetes complications severity index in claims data
-
23198714
-
Chang HY, Weiner JP, Richards TM, Bleich SN, Segal JB. Validating the adapted diabetes complications severity index in claims data. Am J Manag Care. 2012;18:721-6.
-
(2012)
Am J Manag Care.
, vol.18
, pp. 721-726
-
-
Chang, H.Y.1
Weiner, J.P.2
Richards, T.M.3
Bleich, S.N.4
Segal, J.B.5
-
12
-
-
33745814404
-
Are claims data accurate enough to identify patients for performance measures or quality improvement? the case of diabetes, heart disease, and depression
-
16849780 10.1177/1062860606288243
-
Solberg LI, Engebretson KI, Sperl-Hillen JM, Hroscikoski MC, O'Connor PJ. Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression. Am J Med Qual. 2006;21:238-45.
-
(2006)
Am J Med Qual.
, vol.21
, pp. 238-245
-
-
Solberg, L.I.1
Engebretson, K.I.2
Sperl-Hillen, J.M.3
Hroscikoski, M.C.4
O'Connor, P.J.5
-
13
-
-
77955096791
-
Validating ICD coding algorithms for diabetes mellitus from administrative data
-
20363043 10.1016/j.diabres.2010.03.007
-
Chen G, Khan N, Walker R, Quan H. Validating ICD coding algorithms for diabetes mellitus from administrative data. Diabetes Res Clin Pract. 2010;89:189-95.
-
(2010)
Diabetes Res Clin Pract.
, vol.89
, pp. 189-195
-
-
Chen, G.1
Khan, N.2
Walker, R.3
Quan, H.4
-
14
-
-
27744568384
-
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
-
16224307 10.1097/01.mlr.0000182534.19832.83
-
Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-9.
-
(2005)
Med Care.
, vol.43
, pp. 1130-1139
-
-
Quan, H.1
Sundararajan, V.2
Halfon, P.3
-
15
-
-
84890549431
-
-
US Department of Labor, Bureau of Labor Statistics. Consumer Price Index Series ID: SUUR0000SAM. Washington, DC: U.S. Dept. of Labor, Bureau of Labor Statistics Last accessed August 28, 2013
-
US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999-2008, Medical Care. Series ID: SUUR0000SAM. Washington, DC: U.S. Dept. of Labor, Bureau of Labor Statistics, 2008. http://data.bls.gov/cgi-bin/surveymost?su. Last accessed August 28, 2013.
-
(2008)
Chained Consumer Price Index for All Urban Consumers (C-CPI-U) 1999-2008, Medical Care
-
-
-
16
-
-
81255124243
-
Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID
-
21892858 10.3111/13696998.2011.605818
-
Baser O, Wei W, Baser E, Xie L. Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID. J Med Econ. 2011;14:673-80.
-
(2011)
J Med Econ.
, vol.14
, pp. 673-680
-
-
Baser, O.1
Wei, W.2
Baser, E.3
Xie, L.4
-
17
-
-
82355180949
-
A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens
-
1:CAS:528:DC%2BC3MXhsVyrtL%2FE 22038703 10.1007/s12325-011-0074-5
-
Xie L, Wei W, Pan C, Du J, Baser O. A real-world study of patients with type 2 diabetes initiating basal insulins via disposable pens. Adv Ther. 2011;28:1000-11.
-
(2011)
Adv Ther.
, vol.28
, pp. 1000-1011
-
-
Xie, L.1
Wei, W.2
Pan, C.3
Du, J.4
Baser, O.5
-
18
-
-
84875205714
-
Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus
-
1:CAS:528:DC%2BC3sXktV2rtbw%3D 23336845 10.1089/dia.2012.0253
-
Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus. Diabetes Technol Ther. 2013;15:230-6.
-
(2013)
Diabetes Technol Ther.
, vol.15
, pp. 230-236
-
-
Xie, L.1
Zhou, S.2
Wei, W.3
Gill, J.4
Pan, C.5
Baser, O.6
-
19
-
-
84855846339
-
Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting
-
21550952 10.4158/EP10401.OR
-
Davis SN, Wei W, Garg S. Clinical impact of initiating insulin glargine therapy with disposable pen versus vial in patients with type 2 diabetes mellitus in a managed care setting. Endocr Pract. 2011;17:845-52.
-
(2011)
Endocr Pract.
, vol.17
, pp. 845-852
-
-
Davis, S.N.1
Wei, W.2
Garg, S.3
-
20
-
-
84862108594
-
Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes
-
3329848 22432106 10.2337/dc11-2048
-
Zhao Y, Campbell CR, Fonseca V, Shi L. Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes. Diabetes Care. 2012;35:1126-32.
-
(2012)
Diabetes Care.
, vol.35
, pp. 1126-1132
-
-
Zhao, Y.1
Campbell, C.R.2
Fonseca, V.3
Shi, L.4
-
21
-
-
83655184782
-
Achieving a clinically relevant composite outcome of an HbA1c of < 7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme
-
1:CAS:528:DC%2BC38XhvFOmsb4%3D 21883806 10.1111/j.1463-1326.2011.01493.x
-
Zinman B, Schmidt WE, Moses A, Lund N, Gough S. Achieving a clinically relevant composite outcome of an HbA1c of < 7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme. Diabetes Obes Metab. 2012;14:77-82.
-
(2012)
Diabetes Obes Metab.
, vol.14
, pp. 77-82
-
-
Zinman, B.1
Schmidt, W.E.2
Moses, A.3
Lund, N.4
Gough, S.5
-
22
-
-
84862207266
-
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
-
1:CAS:528:DC%2BC38Xos1Wkurs%3D 10.1038/ijo.2011.158
-
Astrup A, Carraro R, Finer N, et al. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes. 2012;36:843-54.
-
(2012)
Int J Obes.
, vol.36
, pp. 843-854
-
-
Astrup, A.1
Carraro, R.2
Finer, N.3
|